The intestinal mucosal barrier controlling the resident microbiome is dependent on a protective mucus layer generated by goblet cells, impairment of which is a hallmark of the inflammatory bowel disease, ulcerative colitis. Here, we show that IL-18 is critical in driving the pathologic breakdown of barrier integrity in a model of colitis. Deletion of Il18 or its receptor Il18r1 in intestinal epithelial cells (D/EC) conferred protection from colitis and mucosal damage in mice. In contrast, deletion of the IL-18 negative regulator Il18bp resulted in severe colitis associated with loss of mature goblet cells. Colitis and goblet cell loss were rescued in Il18bp À/À ;Il18r D/EC mice, demonstrating that colitis severity is controlled at the level of IL-18 signaling in intestinal epithelial cells. IL-18 inhibited goblet cell maturation by regulating the transcriptional program instructing goblet cell development. These results inform on the mechanism of goblet cell dysfunction that underlies the pathology of ulcerative colitis.
INTRODUCTION
Inflammatory bowel disease (IBD) is a complex and debilitating disorder that can be sub-classified into the distinct multifactorial disorders Crohn's disease (CD) and ulcerative colitis (UC) (Kaser et al., 2010; Maloy and Powrie, 2011) . While both are characterized by chronic relapsing pathogenic inflammation and intestinal epithelial cell injury, they differ substantially in their clinical manifestations. CD patients exhibit discontinuous lesions throughout the entirety of the intestinal tract and disease pathology is closely associated with a dysregulation of the antimicrobial peptide (AMP) response (Fellermann et al., 2003; Neurath, 2014) . A genetic basis for CD susceptibility has been linked to genes involved in autophagy and ER stress (e.g., Atg16l1 and Xbp1), as well as microbial recognition (e.g., Nod2), in AMP-producing Paneth cells (Adolph et al., 2013; Cadwell et al., 2008; Hugot et al., 2001; Ogura et al., 2001 ). Interestingly, however, no major defects in AMP production have been observed in UC patients (Nuding et al., 2007; Wehkamp et al., 2007) , indicating distinct mechanistic differences in disease etiology. Despite UC having greater worldwide prevalence than CD (Danese and Fiocchi, 2011) , surprisingly little is known about the specific underlying host factors that drive susceptibility to disease. One unique and defining feature of human UC pathology is major depletion of mucin-producing goblet cells and the mucus layer, which correlates with increased microbiota-induced colonic inflammation and disease pathology (McCormick et al., 1990; Pullan et al., 1994; Strugala et al., 2008; Trabucchi et al., 1986) . Intriguingly, the in vivo mechanisms responsible for this important clinical observation during inflammation remain obscure.
Members of the IL-1 family of cytokines play critical roles in intestinal homeostasis and inflammation (Lopetuso et al., 2013; Neurath, 2014; Saleh and Trinchieri, 2011) . In particular, IL-18 has emerged as an indispensable factor in governing host-microorganism homeostasis and has been postulated to be a key determining factor in IBD (Dinarello et al., 2013; Elinav et al., 2011; Nakamura et al., 1989) . IL-18 is initially synthesized as an inactive precursor molecule that requires coordinated inflammasome activation of the cysteine protease caspase-1 to cleave proIL-18 into a functional mature bioactive cytokine Martinon et al., 2002) . Upon activation and release, IL-18 is free to bind the IL-18 receptor alpha chain (IL-18R1) and in cells co-expressing the IL-18R accessory protein (IL18Rap), ligand binding triggers receptor heterodimerization and the formation of an intracellular Myd88 signaling platform Born et al., 1998; Hoshino et al., 1999) . This elicits the recruitment of IRAK and TRAF6, facilitating activation of the inhibitor of kB (IkB) kinases (IKKs), IKKa and IKKb (Medzhitov et al., 1998; Mercurio et al., 1997) . In turn, IKKb can phosphorylate IkBa, targeting the protein for proteasomal degradation and allowing the NF-kB subunit p65 to translocate to the nucleus to initiate diverse gene expression programs such as proinflammatory cytokine production and NOD-Like Receptor (NLR) upregulation (Bauernfeind et al., 2009 ). As such, IL-18 signaling requires tight regulation to prevent autoimmunity and this is thought to be directly accomplished by the soluble decoy receptor IL-18 binding protein (IL-18BP), as its transgene overexpression has been shown to neutralize IL-18 activity in vivo to prevent hyper NF-kB activation and inflammation (Fantuzzi et al., 2003) .
The use of IL-18-and IL-18R1-deficient mice identified IL-18 as a putative host molecule required to protect intestinal epithelial cells from intestinal inflammation and colitis (Salcedo et al., 2010) . In support of a role for IL-18 in promoting intestinal epithelial integrity and protection from acute experimental colitis, mice deficient in the key processing subunits of IL-18, caspase 1, and the NLRP3 inflammasome are also highly susceptible to disease pathology (Dupaul-Chicoine et al., 2010; Zaki et al., 2010) . Administration of exogenous recombinant IL-18 rescues colitis in the aforementioned and other inflammasome-deficient mice, further supporting a protective role for IL-18 in colitis (Oficjalska et al., 2015) . In contrast, however, inhibition of IL-18 has also been shown to instigate protection in experimental colitis, supporting a pro-colitogenic role for IL-18 (Kanai et al., 2001; Siegmund et al., 2001; Ten Hove et al., 2001) . Such conflicting findings have led to much controversy and discussion in the field, and the true role of IL-18 in intestinal homeostasis and inflammation is still unresolved (Asquith and Powrie, 2010; Dinarello et al., 2013; Gagliani et al., 2014; Siegmund, 2010) .
Underlying this discourse is the fact that most previous work studying the complete IL-18 deletion in mice is confounded by IL-18 effect on colitogenic microbiota (Elinav et al., 2011; Henao-Mejia et al., 2012) , while equally important roles of IL-18 during inflammation are masked by dysbiosis. Compound-associated phenotypic alterations in Il18 À/À mice such as metabolic syndrome may further obscure the direct contribution of IL-18 to intestinal function (Netea et al., 2006) . At present, no genetic models exist to specifically dissect the role of IL-18 in colitis risk, and the need for new genetic tools is therefore paramount.
To this end, we generated conditional knockout mice for both IL-18 and IL-18R1 to delineate the direct involvement of IL-18 in epithelial and hematopoietic cells to homeostasis and colitis. Here, we show that IL-18 production, irrespective of its cellular source, exacerbated colitis severity after administration of the colitis-inducing agent dextran sodium sulfate (DSS). Deletion of IL-18R in epithelial cells (Il18r
) protected mice from developing colitis, suggesting that IL-18 directly disrupts epithelial cell integrity during colitis. By deleting IL-18 binding protein (Il18bp), the IL-18 negative regulator, we asked if increased bioavailability of IL-18 would promote barrier function or rather drive colitis. Remarkably, Il18bp À/À mice developed severe colitis associated with progressive loss of mature goblet cells, which could be reversed by specifically deleting the epithelial IL-18R in these mice. Finally, we show that IL-18-mediated goblet cell dysfunction precedes clinical disease manifestation and is caused by a defect in terminal goblet cell maturation through transcriptional regulation of goblet cell differentiation factors. Taken together, these results uncover the direct role of IL-18 in promoting goblet cell dysfunction during colitis, leading to breakdown of the mucosal barrier. This study may therefore offer a genetic understanding to the pathology of human ulcerative colitis. Figure 1A ). Colonoscopy performed on day 7 post DSS showed increased tissue damage in control Il18 fl/fl mice, measured by the degree of bleeding, colon wall granularity and translucency, as well as stool consistency ( Figure 1B Figure 1F ). These results suggest that IL-18 promotes the pathology of DSS-induced colitis through a mechanism dependent on its action on intestinal epithelial cells.
RESULTS

Hematopoietic/Endothelial IL-18, but Not IL-18R, Promotes DSS-Induced Colitis
In addition to epithelial cells, IL-18 and IL-18R are also expressed by various hematopoietic and endothelial cells, in particular under inflammatory conditions (Siegmund, 2010) . To address the role of the IL-18 axis in these cells during colitis, we generated (D) Littermate Il18r fl/fl and Il18r D/EC mice were cohoused with Il18 À/À mice for 8 weeks, after which DSS was administered and weight loss recorded (n = 7-13). sion levels of Il18bp in the steady-state colon were low, it was highly induced during the course of colitis, returning to baseline levels following recovery ( Figure 3A ). To better understand the mechanism by which IL-18 enhances susceptibility to colitis, we generated mice with hyperactive IL-18 signaling by deleting Il18bp (Figure S1E ). Il18bp expression was undetectable in Il18bp À/À mice, whereas the expression of neighboring genes was unaffected ( Figure S1F ). Furthermore, in the steady-state Il18bp À/À mice had equalized flora compared to their wild-type (WT) littermates ( Figure S2E ) and displayed normal goblet cell development and tight junction structure ( Figure S3 ). Although Il18 mRNA expression was comparable in WT and Il18bp À/À mice, the active secreted form of IL-18 was elevated in Il18bp À/À colon explant supernatants, both in the steady state and following DSS treatment ( Figure 3B ). During DSS colitis, Il18bp À/À mice developed rapid and severe morbidity associated with extensive bleeding and tissue damage ( Figures 3C and 3D ). Extensive tissue deterioration and colitis were also evident in histological sections of Il18bp À/À mice but not of their WT littermate controls (Figure 3E) . Remarkably, Il18bp À/À mice suffered an overwhelming loss of mucus-producing goblet cells ( Figure 3E ). The absence of mature goblet cells and associated mucus layer in Il18bp À/À mice was verified by AB/PAS staining ( Figure 3E ). Goblet cell enumeration in histological sections showed a dramatic decrease in goblet cell counts in Il18bp À/À mice compared to WT mice at day 8 post DSS ( Figure 3E ). Figure 4A ). This corre- Figure 4D ; compare to Figure 3E ). These results indicate that goblet cell loss and increased susceptibility to colitis are a direct consequence of increased IL-18 signaling in intestinal epithelial cells.
Hyperactive IL-18 Signaling Prevents Goblet Cell Maturation Prior to Colitis
To determine whether the observed goblet cell dysfunction is a cause rather than a consequence of inflammation, we examined histological colon sections from Il18bp À/À mice at day 4 post Figure S4D ). To determine whether dysregulation of goblet cell maturation reflects a transcriptional imbalance, we measured expression of transcription factors involved in goblet cell differentiation and maturation. Whereas no change was noted in the secretory lineage differentiation factors Math1 (Hath1; Atoh1) and Hes1, expression of the goblet cell differentiation/maturation factors Gfi1, Spdef, and Klf4 was markedly inhibited in Il18bp À/À mice ( Figure 5D ). These results suggest that IL-18 promotes colitis by preventing functional goblet cell maturation through regulation of the goblet cell transcriptional maturation program.
IL-18 Directly Controls Goblet Cell Maturation and Colitis
We finally assessed the direct role of IL-18 in goblet cell dysfunction leading to colitis, by injecting recombinant IL-18 protein to WT mice during the course of DSS administration. Disease severity was increased in mice receiving daily IL-18 injections, as determined by weight loss and macroscopic examination of the colon at day 8 post DSS ( Figures 6A and 6B ). In line with our observations in Il18bp À/À mice, AB/PAS staining showed gradual decrease in the abundance of mature PAS + goblet cells in mice receiving IL-18 compared to PBS ( Figure 6C ). The state of goblet cell maturation was corroborated in colon sections obtained following 5 daily injections prior to weight loss and clinical symptoms of colitis, demonstrating an IL-18-mediated block in goblet cell maturation ( Figures 6D and 6E ). The ratio of mature/immature goblet cell decreased further in IL-18-injected mice on day 8 ( Figures S4D  and S4E ). IL-18 injection was sufficient to reduce Gfi1, Spdef, and Klf4 gene expression in isolated IECs, further supporting direct regulation of goblet cell maturation by IL-18 ( Figure 6F ). These results suggest that elevated IL-18 production during inflammation is responsible for dysregulated goblet cell maturation.
DISCUSSION
Despite great strides in our understanding of IL-18 over the past 15 years, its precise contributions to host homeostasis, intestinal inflammation, and its overall relevance to IBD still remain controversial and elusive. On one hand, complete loss of IL-18 (or IL-18R) predisposes mice to increased intestinal epithelial damage and fosters an altered inflammatory environment that potentiates intestinal tumor formation (Salcedo et al., 2010; Takagi et al., 2003) . This could be explained, at least in part, by the recently identified role of IL-18 in controlling the outgrowth of colitogenic bacterial species (Elinav et al., 2011) . On the other hand, IL-18 is a potent proinflammatory cytokine with the ability to promote colitis through the induction of inflammatory mediators such TNFa and chemokines (Sivakumar et al., 2002; Ten Hove et al., 2001 ).
The role of IL-18 in intestinal homeostasis and inflammation and its mechanistic segregation from microbiota-dependent functions therefore remained unresolved.
Previous interpretations of IL-18 functionality have been limited by the lack of precise genetic models required to systematically determine its roles in intestinal biology. Therefore, IL-18 function has been inferred from complete deletion of IL-18, inflammasomes, caspase 1/11, or the multifunctional adaptor protein ASC. Such studies have led to the conclusion that epithelialderived IL-18 is required to promote barrier integrity during early inflammation, as acute treatment with recombinant IL-18 during early colitis promotes epithelial proliferation in inflammasomedeficient mice, rescuing intestinal pathology (Dupaul-Chicoine et al., 2010; Zaki et al., 2010) . However, extrapolation of direct IL-18 functionality from these models should be approached with caution. First, deficiency of NLRP3, which is highly expressed in the myeloid compartment, results in numerous phenotypic alterations beyond IL-18 processing. Most obvious is an inherent defect in processing the closely related and equally important cytokine IL-1b. Like IL-18, IL-1b is also thought to mediate a dichotomous role in intestinal homeostasis and inflammation (Bamias et al., 2012; Lopetuso et al., 2013) . Notably, bone marrow chimera experiments have shown that hematopoietic-derived IL-1b is also sufficient to rescue epithelial cell damage and promote epithelial restitution during experimental colitis (Bersudsky et al., 2014) . Therefore, in NLRP3-deficient mice, which harbor defects in IL-1 family member maturation, IL-18 may compensate for the lack of IL-1b; however, whether this occurs physiologically (or at physiologically relevant levels of IL-18) remains unclear. In addition, caspase 1 plays a key role in the clearance of intracellular intestinal pathogens through the regulated cell death process of pyroptosis (Miao et al., 2010) . Although the role of pyroptosis in colitis is still under investigation, the use of pyroptosis-defective mice to examine the specific IL-18 functionality in the intestine proves problematic. The study of direct functions of IL-18 in the intestine is further complicated by NLRP6 regulation of dysbiosis and the outgrowth of pathogenic intestinal microbial communities (Elinav et al., 2011) . As demonstrated by Levy et al. (2015) in this issue of Cell, IL-18 processing by the NLRP6 inflammasome shapes the steady-state host-microbiome interface by regulating the downstream anti-microbial peptide (AMP) landscape, thereby maintaining intestinal homeostasis. Normally, this axis is controlled by indigenous microbiota-modulated metabolites. However, it can also be directly subverted by inflammasome suppressing metabolites derived from a disease-causing microbiota, which hijacks this pathway, thereby facilitating dysbiosis development and persistence in an invaded host. This highlights the (legend continued on next page) importance of using cohoused littermate control mice, as in the present study, as they harbor near identical bacterial species enabling distinction of the genetic contribution of IL-18 from that of flora driven inflammation.
In this study, we show that during inflammation, not only is IL-18 production in intestinal epithelial and hematopoietic cells not required for protection against experimental colitis, IL-18 signaling in epithelial cells amplifies intestinal damage. This pathogenic role of IL-18 correlates with clinical observations whereby an increase in both epithelial and hematopoietic IL-18 expression and cytokine bioreactivity have been demonstrated in patients with increased severity of IBD (Monteleone et al., 1999; Pizarro et al., 1999) . However, the mechanism through which this upregulation of IL-18 in the intestine may contribute to increased disease severity was unknown. An emerging realization in the complexity of IBD is that pathology is not wholly shaped by a dysregulated immune response but highly dependent on an intact mucosal barrier and coordinated cross talk between the intestinal epithelial and immune cells with the microbiota (Kaser et al., 2011; Schreiber et al., 2005; Xavier and Podolsky, 2007) . One possible mechanism to explain this association is that increased IL-18 release from epithelial cells acts on resident immune cell to upregulate IL-18 and other proinflammatory mediators, which induce endothelial VCAM-1 expression to enhance immune cell infiltration into the mucosa and together trigger severe auto-inflammation. In support of this model, we show that deletion of IL-18 production in the hematopoietic compartment results in significant amelioration of intestinal damage during colitis. However, deletion of IL-18R signaling in the hematopoietic compartment fails to rescue mice from DSSinduced inflammation. This suggests that the pathology driven by IL-18 does not occur via signaling in hematopoietic cells, in line with previous reports (Dupaul-Chicoine et al., 2010; Malvin et al., 2012; Saleh and Trinchieri, 2011; Zaki et al., 2010) . Rather, we found that deletion of the IL-18R from intestinal epithelial cells dramatically protects mice from DSS-induced colitis, suggesting that elevated IL-18 expression during colitis is directly pathogenic to the epithelial cell barrier.
Ulcerative colitis is characterized by mucosal barrier dysfunction, most notably in epithelial goblet cells and mucus production (Danese and Fiocchi, 2011; Gersemann et al., 2009; McCormick et al., 1990; Pullan et al., 1994; Trabucchi et al., 1986) . As goblet cell secretion of protective mucins, trefoil factors, and other proteins is essential for barrier integrity and for preventing microflora-driven intestinal inflammation, such dysregulation underlies the pathology exhibited in UC patients. In order to investigate how IL-18 may specifically contribute to intestinal barrier breakdown during DSS colitis, we deleted its decoy receptor inhibitor, IL-18BP. Interestingly, Il18bp À/À mice were characterized by increased colitis severity and lethality associated with major depletion of mature goblet cells, which was reversed in
;Il18r D/EC double knockout mice. Thus, excessive IL-18 signaling on the epithelium leads to progressive depletion of goblet cells and may represent a major risk factor for intestinal inflammation and UC. As severe intestinal inflammation has previously been suggested to result in goblet cell depletion (Bergstrom et al., 2008) , we analyzed mice during preclinical manifestation of colitis in order to explore mechanistically if IL-18 was the key determining factor governing goblet cell loss and risk for colitis. Whereas we observed no discernible differences in goblet cell numbers at preclinical time points, we instead discovered that IL-18 promotes disequilibrium in the state of goblet cell development and maturation, decreasing the pool of functional mature goblet cells. Studies on the transcriptional regulation of intestinal lineage determination have identified the factors controlling goblet cell differentiation and maturation (McCauley and Guasch, 2015) . Notch1 signaling drives epithelial progenitor cell specification to absorptive enterocytes and inhibits secretory cell differentiation via the Hes1 transcription factor (Fre et al., 2005; Jensen et al., 2000) , whereas Notch1 inhibition results in robust conversion of proliferating crypt progenitors into terminally differentiated goblet cells (van Es et al., 2005) . Below a threshold of Notch1 signal, upregulation of Math1 (also known as Hath1, Atoh1) governs commitment of progenitor cells to the epithelial secretory cell lineages, including goblet cells, Paneth cells, and neuroendocrine cells (Yang et al., 2001 ). The transcriptional repressor Gfi1 functions downstream of Math1 to control intestinal secretory cell differentiation, specification, and maintenance and is required for goblet and Paneth cell development (Shroyer et al., 2005) . The transcription factors Spdef and Klf4 in turn control goblet cell development and maturation downstream to Gfi1 and are essential for mucosal barrier protection (Gregorieff et al., 2009; Katz et al., 2002; Noah et al., 2010) . Analysis of the lineage commitment transcription factors Hes1 and Math1 in the intestinal epithelium of mice with hyperactive IL-18 did not indicate dysregulation at the lineage specification level. Conversely however, the downstream secretory lineage transcription factor Gfi1 and the terminal goblet cell maturation effectors Spdef and Klf4 were markedly downregulated by IL-18. Importantly, all three transcription factors are required to be constitutively expressed in mature goblet cells and loss of either Gfi1, Spdef, or Klf4 expression was shown to result in loss of mature goblet cells (Gregorieff et al., 2009; Katz et al., 2002; Shroyer et al., 2005) . These data highlight an unexpected role for IL-18 signaling in directly modulating goblet cell maturation and fate downstream to secretory lineage commitment during intestinal inflammation.
In conclusion, we propose that a strict equilibrium of epithelial IL-18 signaling must be maintained in order to preserve its homeostatic functions while preventing progressive loss of mature goblet cells and increased risk of colitis. This work suggests that IL-18 targeting or specific targeting of epithelial IL-18R may (D) Epifluorescence images (left, top right panels) and confocal stacks (bottom right panels) of distal colon sections obtained on day 5 post DSS and stained with UEA-1 and anti-MUC2. Scale bar, 150 mm. (E) Enumeration of immature and mature goblet cells in distal colon sections stained as in (D). Immature and mature goblet cells were scored as in Figure 5C . (F) Distal colon samples were obtained on day 8 post DSS and used for gene expression analysis by qPCR. Data are represented as mean ± SEM. *p < 0.05; **p < 0.01; ****p < 0.0001 by unpaired Student's t test. See also Figure S4 . represent a novel strategy to prevent the pathologic breakdown of the mucosal barrier in human ulcerative colitis.
EXPERIMENTAL PROCEDURES Mice
Conditional knockout mice with floxed IL-18 alleles or floxed IL-18R alleles were generated using standard homologous gene recombination techniques (Rongvaux et al., 2014) . Il18 À/À mice have been previously reported . Il18bp deletion was generated using Cas9/CrispR technology as described (Wang et al., 2013) . All experiments were performed using cohoused littermate control mice. 
Experimental Colitis
For acute experimental colitis induction, mice were administered 2% DSS (M.W. = 36,000-50,000 Da; MP Biomedicals) in their drinking water ad libitum for 7 days, followed by regular drinking water. According to the animal protocol, mice were sacrificed if they lost more than 30% of their initial body weight.
Colonoscopy
Colonoscopy was performed using a high resolution mouse video endoscopic system (''Coloview,'' Carl Storz). The severity of colitis was blindly scored using MEICS (Murine Endoscopic Index of Colitis Severity) based on four parameters: granularity of mucosal surface, vascular pattern, translucency of the colon mucosa, and stool consistency (Becker et al., 2006) .
Histology
Colons were fixed in Bouin's medium and embedded in paraffin. Blocks were serially sectioned along the cephalocaudal axis of the gut to the level of the lumen; the next 5 mm-thick section was stained with H&E. For goblet cell and mucus layer preservation ex vivo, immediately after excision, colons were submerged in Ethanol-Carnoy's fixative at 4 C for 2 hr and then placed into 100% ethanol. Fixed colon tissues were embedded in paraffin and cut into 5-mm sections. Tissues were stained with Alcian blue/PAS. Images were acquired with Leica DMI6000B inverted microscope, and data were analyzed using the LAS-AF software. 
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